Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms

International Forum of Allergy and Rhinology

Volumn 1, Issue 5, 2011, Pages 329-334

  Biel, Merrill A ^a,b   Sievert, Chet ^b   Usacheva, Marina ^b   Teichert, Matthew ^b   Balcom, Jim ^c  

^a Ear Nose and Throat Specialty Care of Minnesota   (United States)

^b Advanced Photodynamic Technologies Inc   (United States)

^c Sinuwave Inc   (United States)

Author keywords

Antibiotic resistant bacteria; Biofilms; Chronic sinusitis; Photodynamic therapy; Planktonic microorganisms

Indexed keywords

METHYLENE BLUE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CHRONIC RECURRENT SINUSITIS; CHRONIC SINUSITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHOTODYNAMIC THERAPY; PLANKTON; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOFILMS; CHRONIC DISEASE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PHOTOCHEMOTHERAPY; PLANKTON; PSEUDOMONAS AERUGINOSA; SINUSITIS; TREATMENT OUTCOME;

EID: 84861412508     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.20089     Document Type: Article

References (57)

1. Marple BF, Stankiewicz JA, Baroody FM, et al. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009;121:121-139.
2. National Center for Health Statistics (NCHS). Chronic sinusitis. In: Summary Health Statistics for US Adults, 2002. Hyattsville, MD: Centers for Disease Control, U.S. Department of Health and Human Services; 2002.
3. Murphy MP, Fishman P, Short SO, et al. Health care utilization and cost amount adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg. 2002;127:367-376.
4. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg. 1995;113:104-109.
5. Hamilos DL. Chronic sinusitis. J Allergy Clin Immunol. 2000;106:213-227.
6. Somerville LL. Hidden factors in asthma. Allergy Asthma Proc. 2001;22:341-345.
7. Chester AC. Health impact of chronic sinusitis. Otolaryngol Head Neck Surg. 1999;114:842-849.
8. Desrosiers MY, Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: what to do when antibiotics, steroids and surgery fail. Rhinology. 2008;46:3-14.
9. Cohen M, Kofonow J, Nayak JV, et al. Biofilms in chronic rhinosinusitis: a review. Am J Rhinol Allergy. 2009;23:255-260.
10. Kilty SJ, Desrosiers MY. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis? Immunol Allergy Clin North Am. 2009;29:645-656.
11. Foreman A, Psaltis AJ, Tan LW, Wormald P. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:556-561.
12. Hunsaker DH, Leid JG. The relationship of biofilms to chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2008;16:237-241.
13. Kilty SJ, Desrosiers MY. The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2008;8:227-233.
14. Daele JJ. Chronic sinusitis in children. Acta Otorhinolaryngol Belg. 1997;51:285-304.
15. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope. 2006;116:1121-1126.
16. Cryer J, Schipor L, Perloff JR, Palmer JN. Evidence of bacterial biofilms in human chronic sinusitis. ORL J Otorhinolaryngol Relat Spec. 2004;66:155-158.
17. Ferguson BJ, Stolz, DB. Demonstration of biofilm in human bacterial chronic rhinosinusitis. Am J Rhinol. 2005;19:452-457.
18. Palmer JN. Bacterial biofilms: do they play a role in chronic sinusitis. Otolaryngol Clin North Am. 2005;38:1193-1201.
19. Harvey RJ, Lund VJ. Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology. 2007;45:3-13.
20. Palmer JN. Bacterial biofilms in chronic rhinosinusitis. Ann Otol Rhinol Laryngol. 115(9 SUPPL 196):35-39.
21. Ramadan HH, Sanclement JA, Thomas JG. Chronic rhinosinusitis and biofilms. Otolaryngol Head Neck Surg. 2005;132:414-417.
22. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope. 2005;115:578-582.
23. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-138.
24. Teichert MC, Jones JW, Usacheva MN, Biel MA. Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:155-160.
25. Usacheva MN, Teichert MC, Biel MA. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med. 2001;29(2):165-173.
26. Usacheva MN, Teichert MC, Biel MA. The role of the methylene blue and toluidine blue monomers and dimers in the photoactivation of bacteria. J Photochem Photobiol B. 2003;71:87-98.
27. Usacheva MN, Teichert MC, Sievert CE, Biel MA. Effect of Ca+ on the photobactericidal efficacy of methylene blue and toluidine blue against gram-negative bacteria and the dye affinity for lipopolysaccharides. Lasers Surg Med. 2006;38:946-954.
28. Usacheva MN, Teichert MC, Sievert CE, Biel MA. Interaction of the photobactericides methylene blue and toluidine blue with a fluorophore in Pseudomonas aeruginosa cells. Lasers Surg Med. 2008;40:55-61.
29. Wainwright M, Phoenix DA, Nickson PB, Morton G. The use of new methylene blue in Pseudomonas aeruginosa biofilm destruction. Biofouling. 2002;18:247-249.
30. Jori G, Fabris C, Soncin M, et al. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med. 2006;38:468-481.
31. Wong TW, Wang YY, Sheu HM, et al. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother. 2005;49:895-902.
32. Millson CE, Wilson M, MacRobert AJ. et al. Ex-vivo treatment of gastric Heliobacter infection by photodynamic therapy. J Photochem Photobiol B. 1996;32:59-65.
33. Soukos NS, Wilson M, Burns T, et al. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg Med. 1996;18:253-259.
34. Hamblin MR, Hasan T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci. 2004;3:436-450.
35. Wainwright M, Phoenix DA, Laycock SL, et al. Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett. 1998;160:177-181.
36. Wilson M, Dobson J, Sarker S. Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol. 1993;8:182-187.
37. Wilson M, Pratten J. Sensitization of Staphylococcus aureus to killing by low-power laser light. J Antimicrob Chemother. 1994;33:619-624.
38. Eimer M, Tuite JM, Kelly J. Properties of various dyes. Photochem Photobiol. 1993;321:103.
39. McVae J. Optical properties of natural dyes. Chem Soc Trans. 1870;2:1778.
40. Harris F, Chatfield LK, Phoenix DA. Phenothiazinium based photosensitisers-photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr Drug Targets. 2005;6:615-627.
41. Hejtmancik MR, Ryan MJ, Toft JD et al. Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrate. Toxicol Sci. 2002;65:126-134.
42. Navarro HA, Price CJ. Final Report on the Developmental Toxicity of Methylene Blue Trihydrate (CAS No. 7220-79-3) in Sprague-Dawley (CD) (Trade Name) Rats. Report number: PB93-219582. [Laboratory supplement for the final report, PB93-219574]. Research Triangle Park, NC: National Institute of Environmental Health Sciences (NIEHS); 1993.
43. NTP chemical repository of methylene blue trihydrate. National Toxicology Program (NTP) Health and Safety Report. November 30, 1990; CAS 61-73-4/77220-79-3.
44. Physician's Desk Reference (PDR). 64th ed. Montvale, NJ: PDR Network, LLC; 2010.
45. McEvoy GK, ed. AHFS Drug Information. 49th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007.
46. Danziger RM, Bar-Eli KH, Weiss K. The laser photolysis of methylene blue. J Phys Chem. 1967;71:2633-2640.
47. Gorman AA, Rodgers MA. Lifetime and reactivity of singlet oxygen in an aqueous micellar system: a pulsed nitrogen laser study. Chem Phys Lett. 1978;55:52-54.
48. Kato S, Morita M, Koisumi M. Studies of the transient intermediates in the photoreduction of methylene blue. Bull Chem Soc Jpn. 1964;37:117-124.
49. Martin JP, Logsdon N. Oxygen radicals are generated by dye-mediated intracellular photooxidations: a role for superoxide in photodynamic effects. Arch Biochem Biophys. 1987;256:39-49.
50. Nilsson R, Merkel PB, Kearns DR. Kinetic properties of the triplet states of methylene blue and other photosensitizing dyes. Photochem Photobiol. 1972;16:109-116.
51. Obata H, Kogasaka K, Koizumi M. Photochemical reactions between methylene blue and tri-, di- and monomethylamuine, III. The behavior of methylene blue in the presence of oxygen. Bull Chem Soc Jpn. 1959;32:125-32.
52. Somer G, Green M. Photoreduction of methylene blue in water. Photochem Photobiol. 1963;17:179-190.
53. Andersen R, Loebel N, Hammond D et al. Treatment of periodontal disease by photodisinfection compared to scaling and root planing. J Clin Dent. 2007;18:34-38.
54. Braun A, Dehn C, Krause F, et al. Short-term clinical effects of adjunctive antimicrobial therapy in periodontal treatment: a randomized clinical trial. J Clin Periodontol. 2008;35:877-884.
55. Chondros P, Nikolidakis D, Christodoulides N, Rössler R, Gutknecht N, Sculean A. Photodynamic therapy as adjunct to non-surgical periodontal treatment in patients on periodontal maintenance: a randomized controlled clinical trial. Lasers Med Sci. 2009;24:681-688.
56. Leung KP, Crowe TD, Abercrombie JJ, et al. Control of oral biofilm formation by an antimicrobial decapeptide. J Dent Res. 2005;84:1172-1177.
57. Singh PD, Parsek MR, Greenberg EP, Welsh MJ. A comparison of innate immunity prevents biofilm development. Nature. 2002;417:552-555.